Evidence map›Paper›PMID 22459871›Full record

ReviewAlcohol (Fayetteville, N.Y.)2012

A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.

Matthew J Pava, John J Woodward

Open access · greenAbstract readReview
In one paragraph

Review in Alcohol (Fayetteville, N.Y.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 2 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 2 syntheses or guidelines pooled it, 144 citations in OpenAlex.

  1. Pooled it
  2. Highway to hell or magic smoke? The dose-dependence of ΔLearning & memory (Cold Spring Harbor, N.Y.) · 2018
    Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. "General Addiction Liability" Revisited.Clinical psychological science : a journal of the Association for Psychological Science · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Striatonigral direct pathway 2-arachidonoylglycerol contributes to ethanol effects on synaptic transmission and behavior.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Matthew J PavaDepartment of Neurosciences, Medical University of South Carolina, Charleston, 29403, USA.
John J Woodward
Medical University of South Carolina · US

Funding

TREATING ETHANOL WITHDRAWAL WITH LORAZEPAM/NALTREXONEP50AA010761 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Lisa M McTeague · 1996 to 2026
$46.8M
TRAINING IN ALCOHOL TREATMENT RESEARCHT32AA007474 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI John J. Woodward · 1987 to 2026
$8.5M
Ethanol Sensitivity of Native and Cloned NMDA ReceptorsR37AA009986 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WOODWARD, JOHN J. · 2009 to 2018
$3.8M
Chronic Ethanol's Effects on Endocannabinoid Modulation of Neocrotical Up-statesF31AA018908 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PAVA, MATTHEW JOSEPH · 2009 to 2010
$77k
NIAAA NIH HHS F31 AA018908NIAAA NIH HHS F31AA018908NIAAA NIH HHS P50 AA010761NIAAA NIH HHS P50AA10761NIAAA NIH HHS R37 AA009986NIAAA NIH HHS T32 AA007474
6 · The paper itself

Abstract

Over the past fifty years a significant body of evidence has been compiled suggesting an interaction between the endocannabinoid (EC) system and alcohol dependence. However, much of this work has been conducted only in the past two decades following the elucidation of the molecular constituents of the EC system that began with the serendipitous discovery of the cannabinoid 1 receptor (CB1). Since then, novel pharmacological and genetic tools have enabled researchers to manipulate select components of the EC system, to determine their contribution to the motivation to consume ethanol. From these preclinical studies, it is evident that CB1 contributes the motivational and reinforcing properties of ethanol, and chronic consumption of ethanol alters EC transmitter levels and CB1 expression in brain nuclei associated with addiction pathways. These results are augmented by in vitro and ex vivo studies showing that acute and chronic treatment with ethanol produces physiologically relevant alterations in the function of the EC system. This report provides a current and comprehensive review of the literature regarding the interactions between ethanol and the EC system. We begin be reviewing the studies published prior to the discovery of the EC system that compared the behavioral and physiological effects of cannabinoids with ethanol in addition to cross-tolerance between these drugs. Next, a brief overview of the molecular constituents of the EC system is provided as context for the subsequent review of more recent studies examining the interaction of ethanol with the EC system. These results are compiled into a summary providing a scheme for the known changes to the components of the EC system in different stages of alcohol dependence. Finally, future directions for research are discussed.

Indexed as

EndocannabinoidsAlcoholismAlcohol-Related DisordersAnimalsCannabinoid Receptor ModulatorsCannabinoidsComorbidityDrug ToleranceEthanolHumansMiceRatsReceptor, Cannabinoid, CB1Receptors, CannabinoidStress, PsychologicalSubstance Withdrawal SyndromeCannabinoid Receptor ModulatorsCannabinoidsEndocannabinoidsEthanolReceptor, Cannabinoid, CB1Receptors, Cannabinoid

Identifiers

PMID22459871
PMCPMC3327810
OpenAlexW1977106004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.